Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIF4GD divergent transcript (MIF4GD-DT) is a long non-coding RNA locus on human chromosome 17 (chr17:75271369-75273895, hg38)[1]. It has the approved gene symbol "MIF4GD-DT" and the alias "AC022211.2"[4][5]. As a divergent transcript, it is situated near and transcribed in the opposite direction to the protein-coding MIF4GD gene, which encodes a protein involved in histone mRNA translation and cell proliferation. No protein product is known for MIF4GD-DT; its sequence and function are not well characterized in the literature, and its biological relevance remains unclear[4][5][1]. Disease relevance is speculative and based on database association mining, not experimental evidence[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIF4GD divergent transcript (MIF4GD-DT).